lifestyle.forkstofeet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Larimar Therapeutics
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
March 19, 2026
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
March 4, 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
February 25, 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
February 25, 2026
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
February 24, 2026